U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT06870370) titled 'Role of Non-Selective Beta-Adrenergic Blocker in Severe TBI' on March 06.
Brief Summary: The role of nonselective beta adrenergic blocker as antistress agent in severe traumatic brain injury
Study Start Date: Sept. 20, 2025
Study Type: INTERVENTIONAL
Condition:
Traumatic Brain Injury (TBI) Patients
Intracranial Pressure
Intensive Care Unit
Mortality
Intervention:
DRUG: propranolol
This group Will receive propranolol intravenously at a dose of 1 mg every 6 h for 7 days, and doses will be held if heart rate less than 60 bpm, mean arterial pressure less than 65 mmHg
DRUG: normal saline IV
This group Will receive 1ml of steril...